Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre
Authors:
- 1 June 2022
- journal article
- research article
- Published by Elsevier in Revue Neurologique
- Vol. 178 (6) , 616-623
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategiesNature Reviews Neurology, 2011
- Response to treatment in patients with lewis–sumner syndromeMuscle & Nerve, 2011
- Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesNeurology, 2011
- EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseasesEuropean Journal of Neurology, 2008
- Shortage of human intravenous immunoglobulin—reasons and possible solutionsNature Clinical Practice Neurology, 2007
- Effets immunomodulateurs des immunoglobulines intraveineusesLa Presse Médicale, 2004
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 1994
- A treatable multifocal motor neuropathy with antibodies to GM1 gangliosideAnnals of Neurology, 1988
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981